Pharmacokinetic interaction of drugs, the metabolisable cytochrome P450 isoenzyme CYP2C9

The role of cytochrome P450 isoforms CYP2C9 and in the metabolism of losartan described. Losartan pharmacokinetics data in humans and laboratory animals are presented. Examples of drug-drug interactions of substrate marker losartan of CYP2C9 of with different drugs are given. The results of studies...

Full description

Saved in:
Bibliographic Details
Main Authors: O. G. Gribakina, G. B. Kolyvanov, A. A. Litvin, A. O. Viglinskaya, V. P. Zherdev
Format: Article
Language:Russian
Published: LLC “Publisher OKI” 2020-04-01
Series:Фармакокинетика и Фармакодинамика
Subjects:
Online Access:https://www.pharmacokinetica.ru/jour/article/view/157
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839591702887661568
author O. G. Gribakina
G. B. Kolyvanov
A. A. Litvin
A. O. Viglinskaya
V. P. Zherdev
author_facet O. G. Gribakina
G. B. Kolyvanov
A. A. Litvin
A. O. Viglinskaya
V. P. Zherdev
author_sort O. G. Gribakina
collection DOAJ
description The role of cytochrome P450 isoforms CYP2C9 and in the metabolism of losartan described. Losartan pharmacokinetics data in humans and laboratory animals are presented. Examples of drug-drug interactions of substrate marker losartan of CYP2C9 of with different drugs are given. The results of studies of the effects of afobazole, an inducer (rifampicin) and inhibitors (fluconazole) in effective doses on the pharmacokinetics of losartan.
format Article
id doaj-art-be8d71a044564c0c96c9986dcddfa1cb
institution Matheson Library
issn 2587-7836
2686-8830
language Russian
publishDate 2020-04-01
publisher LLC “Publisher OKI”
record_format Article
series Фармакокинетика и Фармакодинамика
spelling doaj-art-be8d71a044564c0c96c9986dcddfa1cb2025-08-03T13:00:45ZrusLLC “Publisher OKI”Фармакокинетика и Фармакодинамика2587-78362686-88302020-04-01012132156Pharmacokinetic interaction of drugs, the metabolisable cytochrome P450 isoenzyme CYP2C9O. G. Gribakina0G. B. Kolyvanov1A. A. Litvin2A. O. Viglinskaya3V. P. Zherdev4FSBSI «Zakusov Institute of Pharmacology»FSBSI «Zakusov Institute of Pharmacology»FSBSI «Zakusov Institute of Pharmacology»FSBSI «Zakusov Institute of Pharmacology»FSBSI «Zakusov Institute of Pharmacology»The role of cytochrome P450 isoforms CYP2C9 and in the metabolism of losartan described. Losartan pharmacokinetics data in humans and laboratory animals are presented. Examples of drug-drug interactions of substrate marker losartan of CYP2C9 of with different drugs are given. The results of studies of the effects of afobazole, an inducer (rifampicin) and inhibitors (fluconazole) in effective doses on the pharmacokinetics of losartan.https://www.pharmacokinetica.ru/jour/article/view/157цитохром р450cyp2c9лозартанфармакокинетикаметаболизммежлекарственное взаимодействиеафобазолрифампицинфлуконазолcytochrome p450cyp2c9losartanpharmacokineticsmetabolismdrug-drug interactionafobazolerifampicinfluconazole
spellingShingle O. G. Gribakina
G. B. Kolyvanov
A. A. Litvin
A. O. Viglinskaya
V. P. Zherdev
Pharmacokinetic interaction of drugs, the metabolisable cytochrome P450 isoenzyme CYP2C9
Фармакокинетика и Фармакодинамика
цитохром р450
cyp2c9
лозартан
фармакокинетика
метаболизм
межлекарственное взаимодействие
афобазол
рифампицин
флуконазол
cytochrome p450
cyp2c9
losartan
pharmacokinetics
metabolism
drug-drug interaction
afobazole
rifampicin
fluconazole
title Pharmacokinetic interaction of drugs, the metabolisable cytochrome P450 isoenzyme CYP2C9
title_full Pharmacokinetic interaction of drugs, the metabolisable cytochrome P450 isoenzyme CYP2C9
title_fullStr Pharmacokinetic interaction of drugs, the metabolisable cytochrome P450 isoenzyme CYP2C9
title_full_unstemmed Pharmacokinetic interaction of drugs, the metabolisable cytochrome P450 isoenzyme CYP2C9
title_short Pharmacokinetic interaction of drugs, the metabolisable cytochrome P450 isoenzyme CYP2C9
title_sort pharmacokinetic interaction of drugs the metabolisable cytochrome p450 isoenzyme cyp2c9
topic цитохром р450
cyp2c9
лозартан
фармакокинетика
метаболизм
межлекарственное взаимодействие
афобазол
рифампицин
флуконазол
cytochrome p450
cyp2c9
losartan
pharmacokinetics
metabolism
drug-drug interaction
afobazole
rifampicin
fluconazole
url https://www.pharmacokinetica.ru/jour/article/view/157
work_keys_str_mv AT oggribakina pharmacokineticinteractionofdrugsthemetabolisablecytochromep450isoenzymecyp2c9
AT gbkolyvanov pharmacokineticinteractionofdrugsthemetabolisablecytochromep450isoenzymecyp2c9
AT aalitvin pharmacokineticinteractionofdrugsthemetabolisablecytochromep450isoenzymecyp2c9
AT aoviglinskaya pharmacokineticinteractionofdrugsthemetabolisablecytochromep450isoenzymecyp2c9
AT vpzherdev pharmacokineticinteractionofdrugsthemetabolisablecytochromep450isoenzymecyp2c9